Tenax Therapeutics (TENX) Enterprise Value (2016 - 2017)
Historic Enterprise Value for Tenax Therapeutics (TENX) over the last 8 years, with Q3 2017 value amounting to -$8.5 million.
- Tenax Therapeutics' Enterprise Value fell 1412.52% to -$8.5 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$8.5 million, marking a year-over-year decrease of 1412.52%. This contributed to the annual value of -$13.3 million for FY2016, which is N/A changed from last year.
- According to the latest figures from Q3 2017, Tenax Therapeutics' Enterprise Value is -$8.5 million, which was down 1412.52% from -$8.8 million recorded in Q2 2017.
- In the past 5 years, Tenax Therapeutics' Enterprise Value ranged from a high of -$783528.0 in Q2 2013 and a low of -$58.3 million during Q2 2014
- Moreover, its 5-year median value for Enterprise Value was -$8.7 million (2017), whereas its average is -$12.7 million.
- In the last 5 years, Tenax Therapeutics' Enterprise Value plummeted by 734332.75% in 2014 and then soared by 8640.88% in 2015.
- Quarter analysis of 5 years shows Tenax Therapeutics' Enterprise Value stood at -$783528.0 in 2013, then crashed by 7343.33% to -$58.3 million in 2014, then soared by 65.38% to -$20.2 million in 2015, then skyrocketed by 34.22% to -$13.3 million in 2016, then soared by 35.74% to -$8.5 million in 2017.
- Its last three reported values are -$8.5 million in Q3 2017, -$8.8 million for Q2 2017, and -$12.5 million during Q1 2017.